Tetrahydrogestrinone, a designer steroid that was unidentifiable long ago has been identified by researchers at the Olympic Analytical Laboratory at UCLA in Los Angeles.
THG (Tetrahydrogestrinone) was identified after a spent syringe was anonymously provided to the United States Anti-Doping Agency (USADA).
The FDA has advised all health effects in the serious use of designer steroids and said it cannot be legally marketed without approval.
